Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
2 | Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England | ||
3 | Ian Ingram MedPage Today Deputy Managing Editor.
MedPage Today. New York, New York | Lebrikizumab Wins FDA Approval for Eczema - 2 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - 11 months ago | |
4 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 4 months ago FDA OKs First Cellular Therapy for Melanoma - 9 months ago | |
5 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | ||
6 | John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. | Medicare Lags, Medicaid Leads for Biosimilar Uptake - 4 months ago Study Confirms: No Great Options for Treating VEXAS - 6 months ago Novel IL-17A Blocker Continues to Impress in PsA - about 1 year ago 'Naked' Gene Therapy Promising for Osteoarthritis - about 1 year ago Bimekizumab Data in axSpA Look Good Through 1 Year - about 1 year ago | |
7 | David Nield Science Alert Freelance tech, science writer. Marple, Manchester, UK | ||
8 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Biologics Offer New Options in Atopic Dermatitis - 12 months ago New Data on TYK2 Inhibitors for Psoriasis, Psoriatic Arthritis - 12 months ago New Data on CD40 Ligand Inhibitor for Relapsing MS - about 1 year ago IL-13 Blocker for Eczema Maintains Efficacy at Less-Frequent Dosing - about 1 year ago | |
9 | Rick Lange, MD, Texas Tech; Elizabeth Tracey MedPage Today Texas Tech University System, advancing higher education and health care. Lubbock, Texas | ||
10 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland |